| Holder | CTNM | Economics | Votes |
|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 2.8M | 7.24% | 8.04% |
| Jupiter Topco LLC | 2.7M | 6.96% | 7.74% |
Sign up to see all 10.
| Class | Shares outstanding | Held by institutions | Votes a share | Economics a share |
|---|---|---|---|---|
| CTNM | 35.4M | 86.2% | 1 vote | 1 |
| Class B | 3.9M | none filed | no vote | 1 |
SEC filing ctnm-20251231.htm: The dual class structure of our Class A and Class B common stock may limit your ability to influence corporate matters. Holders of our Class A common stock are entitled to one vote per share, while holders of our Class B common stock are not entitled to any votes. Nonetheless, each share of our Class B common stock may be converted at any time into one share of our Class A common stock at the o...
SEC filing ctnm-20260430.htm: You have received these proxy materials because the Board of Directors (our “Board” or the “Board of Directors”) of Contineum Therapeutics, Inc. (“we”, “us,” “our,” the “Company” or “Contineum”) is soliciting your proxy to vote at the 2026 Annual Meeting of Stockholders (the “Annual Meeting”). This proxy statement, along with the accompanying Notice of Annual Meeting of Stockholders, summarizes...
A trend across this company's share classes isn't available yet: each quarter's 13F filings add up shares of classes that differ in economics and votes.
Sign up to see all 5.
Sign up to see all 5.
Sign up to see all 4.
Every notice on Red Flags →A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
MC
Montanova Capital, LLC
|
2.8M | — | Unchanged | 2024 | 0.9% | |
|
Shares held by quarter
|
||||||
|
JH
Janus Henderson Group PLC
|
— | — | SOLD OUT | — | 0.0% | |
|
Shares held by quarter
|
||||||
28 more super investors behind a free account
See every manager holding Contineum Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$16.1M | 982.3K | — | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$10.6M | 646.7K | — | 0.01% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Contineum Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
LD
Lorrain Daniel S.
Insider
|
145.3K | — | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
|
||||||
|
SC
Stengone Carmine N.
Insider
|
17.2K | — | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
|
||||||
1 more holders behind a free account
See every insider and 5%+ holder of Contineum Therapeutics, Inc..
Sign up freeLoading...